ID   Sa3R
AC   CVCL_C8QA
SY   Sa-3R
DR   Wikidata; Q123033395
RX   PubMed=15756446;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C8173; Upper gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8063 ! Sa3
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
RX   PubMed=15756446; DOI=10.3892/or.13.4.709;
RA   Nakatani K., Nakamura M., Uzawa K., Wada T., Seki N., Tanzawa H.,
RA   Fujita S.;
RT   "Establishment and gene analysis of a cisplatin-resistant cell line,
RT   Sa-3R, derived from oral squamous cell carcinoma.";
RL   Oncol. Rep. 13:709-714(2005).
//